LEADER 01415nam  2200361   450 
001 9910688202903321
005 20230624100052.0
035   $a(CKB)5400000000043496
035   $a(NjHacI)995400000000043496
035   $a(EXLCZ)995400000000043496
100   $a20230624d2021      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aMonoclonal Antibodies /$fedited by Nima Rezaei
210  1$aLondon :$cIntechOpen,$d2021.
210  4$dİ2021
215   $a1 online resource (172 pages)
311   $a1-83968-371-6 
320   $aIncludes bibliographical references and index.
330   $aImmune-based therapies are being studied extensively in a variety of immunological conditions due to their high precision and sensitivity. Monoclonal antibody (mAb) technology is a major advancement in the treatment of several infectious diseases, malignancies, and immunological disorders. This book provides comprehensive information about technologies, characterization, and application of mAbs in the clinic and laboratory.
606   $aMonoclonal antibodies
615  0$aMonoclonal antibodies.
676   $a616.0793
702   $aRezaei$b Nima
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688202903321
996   $aMonoclonal antibodies$9708694
997   $aUNINA